Capricor Therapeutics, Inc. News: Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 11/10/22 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
46 | |
| 11/10/22 | Current report filing |
|
|
7 | |
| 11/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/12/22 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
46 | |
| 08/10/22 | Current report filing |
|
|
7 | |
| 07/19/22 | Current report filing |
|
|
5 | |
| 07/07/22 | Statement of changes in beneficial ownership of securities |
|
1 |